Thursday, March 28, 2019 9:22:11 PM
And where would big pharma get all these shares to dump to keep the PPS down? Do I think big pharma has a dog in the fight. You bet I do. They could be working a few angles here. I would be shocked if they weren’t.
I think, and I could be wrong, you are missing the obvious answers. Right in the many filings, in black and white, CELZ openly disclosed that they issued several notes and warrants to pay for all that they doing to commercialize their business. Each are convertible after a time period.
One note is horrible. Way too many shares and way to little cash. It was flat out ugly.
The newer notes are better, have leak out clauses etc. but are still notes and warrants none the less. Anyone can do the math that if ALL were converted the OS could reach 1.2B or so. It’s not bizarre behavior at all.
It is my belief that the note holders are the most likely cause of the selling. Proof of that is that the OS goes up each month. I believe, and CELZ seems to know, that those notes will end soon enough and be offset by revenue making then self sufficient.
The other place we have a huge disconnect is that I can point out 10 things gleaned out of PR’s and or doctors offices that are up and running and even advertising and you will say some things just cannot be verified and are suspect, then jump to CELZ is clearly borderline illegitimate because they refuse to address the trading.
Why so extreme? Why cannot you admit they have done a ton of things, have so much going on and are very legitimate. Why is it all suspect just because the PPS blows. If we stayed at .05 would you be happy and say CELZ is legit?
I think it is crystal clear that on most days there are more notes clearing than there is buying. We need new blood. New eyes. Tons of folks are watching. Waiting for that right day. Will it be when the 10k is out? Nit likely. Will it be when Q1 comes out, or bigger news in between. Probably.
When the spark is lit and this runs, will you say it’s legitimate?
Recent CELZ News
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:00:18 PM
- Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements • PR Newswire (US) • 06/28/2023 12:00:00 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM